Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-1/Smad3 Pathway

Table 2

Echocardiographic left ventricular (LV) parameters in the study groups after treatment with qili qiangxin (QL) ().

Group		EF (%)	FS (%)	LVIDd (mm)	LVIDs (mm)	EDV (mL)	ESV (mL)
Sham	10	77.8 ± 7.1	48.3 ± 8.2	5.9 ± 0.7	3.0 ± 0.6	0.49 ± 0.14	0.07 ± 0.07
CHF	11
QL	8	54.2 ± 10.3	34.3 ± 14.2	6.5 ± 1.2	5.8 ± 0.7	0.73 ± 0.23	0.51 ± 0.12
Valsartan	8	52.7 ± 4.8	28.9 ± 10.7	6.6 ± 0.9	6.0 ± 0.7	0.71 ± 0.37	0.53 ± 0.14

versus the Sham group, versus the CHF group.